digitalization of currency, snippets

Hang Seng Index fell 0.2%, led by Meituan. The Hang Seng Index fell 0.2% to 20,278.66 in Hong Kong for two consecutive days. Meituan dragged down the index the most, falling by 1.7%. Chuangke Industrial Co., Ltd. suffered the biggest decline, falling by 4.1%. In midday trading, 33 of the 83 stocks fell and 46 rose; Three of the four stocks fell, led by industrial and commercial stocks.Barclays lowered its target share price of Nike from $81 to $79.Bain raised its offer for Fuji Software to 9,600 yen per share.

The main contract of the container transport index (European line) fell more than 4.00% in the day and is now reported at 2436.2 points.On the 10th, the continuous beam of Banzhuyuan Bridge of Xiyu High-speed Railway across Chongqing-Guangzhou Expressway was successfully closed, which is the first closed cantilever cast-in-place beam across expressway in Chongqing of Kangyu section of Xiyu High-speed Railway, laying a solid foundation for the construction of girder erection as scheduled. The Banzhuyuan Extra Large Bridge of Xi-Yu High-speed Railway, which was built by China Railway 14th Bureau, has a total length of 1,137.181 meters. The bridge spans the Chongqing-Guangzhou Expressway, with a continuous beam of (48+80+48) meters and cantilever casting with hanging baskets. It is understood that the Xiqiao High-speed Railway connects Shaanxi, Chongqing and Sichuan. After its completion and opening to traffic, it will be connected with Chengdu-Chongqing High-speed Railway, Zhengzhou-Chongqing High-speed Railway and Chongqing-Kunming High-speed Railway under construction, Xi 'an-Yan 'an High-speed Railway and Xi 'an-Shiyan High-speed Railway, which will greatly facilitate people's travel along the route, consolidate and expand the achievements of poverty alleviation, comprehensively promote rural revitalization, help urban-rural integration and regional coordinated development, and form a new pattern of western development. (CCTV News)Hanyu Pharmaceutical Co., Ltd. signed a strategic cooperation agreement with Longma Technology. Recently, Hanyu Biotechnology (Dali) Co., Ltd., a subsidiary of Hanyu Pharmaceutical Co., Ltd., signed a strategic cooperation agreement with Longma Technology Group. The two sides will cooperate in the medical application of industrial cannabis and drug research and development around drugs and cannabinoids.

"Black Myth: Wukong" won three nominations for IGN's annual awards. On December 11th, IGN, the Imagine Games Network, released the nomination list for IGN's 2024 awards. Among them, the domestic 3A masterpiece Black Myth: Wukong was nominated for "Best Action Adventure Game of the Year", "Best PS Game" and "Best Game of the Year".Huaru Technology: A substantial order has been signed in the field of robotics. Huaru Technology was asked whether the company has a substantial order in the field of robotics when it was investigated by the organization. The company said that the intelligent robot target developed by the company comprehensively uses the Internet of Things, simulation, artificial intelligence and other advanced technologies to realistically simulate the combat actions such as intelligent tracking, intelligent obstacle avoidance, automatic team formation, intelligent attack and defense of enemy soldiers or terrorists in a complex battlefield environment. For special forces, security forces, mobile detachments, special police detachments, peacekeeping forces, etc., we will organize practical live-fire tactical confrontation training and inspection exercises in urban blocks, inside building spaces and in the wild environment, and provide a highly intelligent simulation of blue army opponents. The company has signed substantial orders in this field.The global layout will further promote Sannuo Bio-CGM products to enter the European market. Recently, Sannuo Bio-CGM has reached a strategic cooperation with A.Menarini Diagnostics, a leading European medical diagnosis company, and signed an exclusive distribution agreement. The continuous glucose monitoring (CGM) products of Sannuo Bio will be launched in the European market in the form of joint brands of both parties. Sannuo Bio authorized A.Menarini Diagnostics to exclusively sell its CGM products in more than 20 countries and regions in Europe. In the future, the latter will vigorously promote the access, promotion and sales of Sannuo Bio CGM products in the European medical insurance market. Sannuo Bio has been actively deploying its internationalization strategy since its listing, and its iCan CGM is the first continuous glucose monitoring product certified by CE MDR in China. At present, Europe is the second largest market for CGM. In this cooperation, the two sides signed an exclusive distribution contract with considerable volume, which is expected to greatly accelerate the penetration and coverage of Sannuo Bio-CGM products in the European market.